10
Participants
Start Date
November 18, 2024
Primary Completion Date
January 31, 2025
Study Completion Date
May 31, 2025
Keratin hydrolysate
The clinical study will be conducted in two phases. The first phase will aim at characterizing the metabolites present in human serum after consumption of the Kera-Diet® ingredient and at determining the overall absorption peak of the tested ingredient. The second phase will involve collecting sera enriched with metabolites at the absorption peak, following the ingestion of the ingredient. Subsequently, the final objective will be to characterize the influence of these sera enriched with metabolites of interest on the behavior of human skin cell and intestinal epithelial cell cultures.
University Hospital, Clermont-Ferrand, Clermont-Ferrand
Lead Sponsor
Clinic'n'Cell
OTHER
University Hospital, Clermont-Ferrand
OTHER
BCF Life Sciences
INDUSTRY